Raynaud's phenomenon (primary).
Pope
Janet
J
St. Joseph's Health Care, Rheumatology Centre, London, Ontario, Canada.
D017311:Amlodipine / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D006801:Humans; D009257:Nafronyl / Q000627:therapeutic use; D009529:Nicardipine / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D017311:Amlodipine; D009257:Nafronyl; D009529:Nicardipine; D004110:Diltiazem; D009543:Nifedipine